Federal Advocacy

From our lobbying on Capitol Hill to assure that legislation elevates and preserves pure ingredient compounding, to our advocacy before regulatory agencies like the Food & Drug Administration; and from our work with state boards of pharmacy to our counsel and collaboration with standards-setting bodies like the United States Pharmacopeia, APC is active and assertive in representing pharmacy compounding.

We also lead coalitions of sister pharmacy-related groups and work hand-in-hand with partners like National Community Pharmacists Association and the American Pharmacists Association on a range of important issues that impact pharmacy compounding.

And we get stuff done. Our focus includes:

Building a Blueprint for eliminating regulations that do not make patients safer.
Eliminating unnecessary regulations that don’t improve patient safety.
Protecting the essential role of compounding in filling gaps in drug access when drugmakers are unable to meet demand as with GLP-1s.
Helping FDA better anticipate and deal with drug shortages – including leveraging compounding pharmacies.
Providing accurate, factual information about legitimate compounded drugs amid a sea of drugmaker misrepresentations.
Defending access to compounded hormone therapy that patients rely on. Contribute to our campaign at compounding.com.
Filing amicus briefs in key legal cases to protect patient access to compounded medications.
Advocating for 503B sourcing to support patient care and pharmacy flexibility.

Pharmacy compounding continues to be threatened by ill-conceived regulation, making APC’s role even more important. We advocate for sensible, science-based regulation and will continue to fight overreach by regulatory agencies that hinders patient access to physician-prescribed compounded medications.

For more information on our current priorities:

Click here

Events

APC hosts three big events each year

Advocacy

Protecting pharmacy compounding—and the patients it serves

Education